⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5801644 | 0.74 | ALDH1A1 (0.64) | — | |
| Thymine SCHEMBL8304490 | 0.70 | ATAD2 (0.86) | — | |
| SCHEMBL65085 | 0.70 | — | — | |
| SCHEMBL2304446 | 0.70 | — | — | |
| Thymine SCHEMBL5235 | 0.70 | — | — | |
| Fluorouracil SCHEMBL3646 | 0.70 | — | — | |
| Fluorouracil SCHEMBL10017187 | 0.70 | — | — | |
| SCHEMBL13071676 | 0.70 | — | — | |
| SCHEMBL48366 | 0.70 | — | — | |
| SCHEMBL67366 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106471373-B | For treating, diagnosing and the method for prognosis Malignancy | 约瑟卡雷拉斯白血球过多症研究所 | 2019-08-23 | — | — | CN | disclosed |
| CN-108699550-A | Bead impact tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms | 保障生物系统控股有限公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108473575-A | Anti-BCMA polypeptides and proteins | 美国卫生和人力服务部 | 2018-08-31 | — | — | CN | disclosed |
| CN-107641151-A | OSPA chimeras and its purposes in vaccine | 百深公司 | 2018-01-30 | — | — | CN | disclosed |
| CN-103118701-B | OSPA chimeras and their use in vaccines | 百深公司 | 2017-10-24 | — | — | CN | disclosed |
| CN-107254540-A | Detect the probe geometries of nucleic acid differences | 霍夫曼-拉罗奇有限公司 | 2017-10-17 | — | — | CN | disclosed |
| CN-107217051-A | Recognize heat limit markers thing and heat limitation analogies | NSE产品公司 | 2017-09-29 | — | — | CN | disclosed |
| CN-106471373-A | For treat, diagnose and prognosis Malignancy method | 约瑟卡雷拉斯白血球过多症研究所 | 2017-03-01 | — | — | CN | disclosed |
| CN-106163573-A | Compositions and methods for treating and preventing macular degeneration | 建新公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-102459611-B | Gene therapy for neurodegenerative diseases | 建新公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-101918540-B | LINGO-4 antagonist relates to the application in the illness of demyelinate in treatment | BIOGEN MA INC. (US) | 2016-05-11 | — | — | CN | disclosed |
| EP-1472357-A2 | ELONGASE GENE AND METHOD FOR PRODUCING POLYUNSATURATED FATTY ACIDS | BASF Plant Science GmbH (DE) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003064638-A2 | ELONGASE GENE AND METHOD FOR PRODUCING POLYUNSATURATED FATTY ACIDS | BASF PLANT SCIENCE GMBH (DE) | 2003-08-07 | — | — | WO | disclosed |